MaxCyte Sees $30M–$32M Revenue Target for 2026 MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive.

MaxCyte Sees $30M–$32M Revenue Target for 2026: MaxCyte targets $30M–$32M revenue for 2026, citing ExPERT DTx launch and SPL milestones (Seeking Alpha, Mar 25, 2026); execution and milestone timing are decisive. 👈 Read full analysis #MaxCyte #RevenueTarget #ExPERTDTx #SPLMilestones #FinancialGoals